Journal
FOOD ADDITIVES AND CONTAMINANTS PART A-CHEMISTRY ANALYSIS CONTROL EXPOSURE & RISK ASSESSMENT
Volume 38, Issue 3, Pages 488-500Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1080/19440049.2020.1865577
Keywords
Remediation; mycotoxin; deoxynivalenol (DON); detoxification; in vitro; simulated gastro-intestinal tract
Funding
- Nutrition Sciences N.V.
- Hercules [AUGE/17/15]
Ask authors/readers for more resources
An in vitro model was developed to screen potential commercial products for DON detoxification, utilizing a simulated pig gastrointestinal tract and Lemna minor L. aquatic plant bioassay. The model showed promising results in reducing DON in feed and assessing detoxification efficacy of compounds, with the potential for application to other mycotoxins.
Deoxynivalenol (DON) is a type B trichothecene mycotoxin with worldwide high incidence in feed which is produced by Fusarium species. Strategies are needed to eliminate its health risk for livestock and to minimise its economic impact on production. In order to assess the efficacy of potential physical, chemical and biological DON detoxifying agents, a good in vitro model is necessary to perform a fast and high-throughput screening of new compounds before in vivo trials are set up. In this paper, an in vitro model was developed to screen potential commercial products for DON degradation and detoxification. Contaminated feed with potential detoxifying agents are first applied to a simulated gastrointestinal tract (GIT) of a pig, after which detoxification is assessed through a robust, inexpensive and readily applicable Lemna minor L. aquatic plant bioassay which enables evaluation of the residual toxicity of possible metabolites formed by DON detoxifying agents. The GIT simulation enables taking matrix and incubation parameters into account as they can affect the binding, removal or degradation of DON. One product could reduce DON in feed in the GIT model for almost 100% after 6 h. DON metabolites were tentatively identified with LC-MS/MS. This GIT simulation coupled to a detoxification bioassay is a valuable model for in vitro screening and assessing compounds for DON detoxification, and could be expanded towards other mycotoxins.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available